v3.25.3

Unaudited Condensed Consolidated Interim Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current Assets
Cash and cash equivalents		$ 15
Investment in unconsolidated entities held for sale	800	800
Other current assets	25	25
Total Current Assets	1,096	1,111
Total assets	1,096	1,111
Current Liabilities
Trade payable	2,314	2,122
Other accounts liabilities	1,163	1,107
Warrants liability, net	90	90
Notes and Loan payable	1,080	962
Total Current Liabilities	4,647	4,281
Total Liabilities	4,647	4,281
Stockholders’ Deficit
Common stock, 0.001 par value each: 50,000,000 shares authorized as of March 31, 2025 and December 31, 2024, respectively; issued and outstanding 2,719,668 shares as of March 31, 2025 and December 31, 2024.	3	3
Additional paid-in capital	55,133	55,115
Treasury Stock	(33)	(33)
Accumulated deficit	(58,654)	(58,255)
Total Stockholders’ Deficit	(3,551)	(3,170)
Total Liabilities and Stockholders’ Deficit	1,096	1,111
Related Parties
Current Assets
Accounts Receivables – related parties	$ 271	$ 271

Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Cuentas Inc. 10-Q